Understanding Oligometastatic Disease in Prostate Cancer: Insights from PSMA PET Imaging

Key opinion leaders examine the role of advanced imaging agents, particularly PSMA PET and other radiotracers, in identifying and defining oligometastatic disease in patients with prostate cancer.

EP: 1.PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging

EP: 2.Insights into the Benefit of PSMA PET Imaging Alongside Other Conventional Imaging Modalities in Prostate Cancer Care

EP: 3.The Role of PSMA PET in Early Detection and Prostate Cancer Staging

Now Viewing

EP: 4.Understanding Oligometastatic Disease in Prostate Cancer: Insights from PSMA PET Imaging

Video content above is prompted by the following:

• How do imaging agents, such as PSMA PET or other radiotracers, contribute to the detection and characterization of oligometastasis in prostate cancer patients?

Recent Videos